Sanara MedTech Inc. (SMTI)

Sanara MedTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	68	64.99	45.84	24.14	15.59	11.77
Revenue Growth (YoY)	26.98%	41.77%	89.87%	54.90%	32.47%	101.56%
Cost of Revenue	7.62	7.85	6.36	2.31	1.62	1.21
Gross Profit	60.39	57.14	39.48	21.83	13.97	10.56
Selling, General & Admin	60.22	56.99	45.98	28.05	18.67	13.18
Research & Development	3.76	4.13	3.37	0.56	0.04	0
Other Operating Expenses	4	3.68	2.37	0.6	0.29	0.12
Operating Expenses	67.98	64.8	51.71	29.21	19	13.3
Operating Income	-7.59	-7.67	-12.23	-7.38	-5.03	-2.74
Interest Expense / Income	0.74	0.48	0	0	0.01	0.11
Other Expense / Income	-3.45	-3.84	1.55	0.55	-0.69	-0.03
Pretax Income	-4.89	-4.3	-13.78	-7.92	-4.36	-2.81
Income Tax	0	0	-5.84	0	0	0
Net Income	-4.89	-4.3	-7.94	-7.92	-4.36	-2.81
Shares Outstanding (Basic)	8	8	8	7	6	2
Shares Outstanding (Diluted)	8	8	8	7	6	2
Shares Change	3.01%	4.71%	7.70%	28.02%	168.88%	-1.79%
EPS (Basic)	-0.59	-0.52	-1.00	-1.08	-0.76	-1.32
EPS (Diluted)	-0.59	-0.52	-1.00	-1.08	-0.76	-1.32
Free Cash Flow	-3.4	-3.51	-5.7	-4.99	-4.58	-2.35
Free Cash Flow Per Share	-0.40	-0.42	-0.72	-0.68	-0.80	-1.10
Gross Margin	88.80%	87.92%	86.12%	90.43%	89.63%	89.72%
Operating Margin	-11.17%	-11.79%	-26.68%	-30.55%	-32.30%	-23.29%
Profit Margin	-7.19%	-6.62%	-17.31%	-32.81%	-27.95%	-23.92%
Free Cash Flow Margin	-5.00%	-5.40%	-12.43%	-20.65%	-29.38%	-19.97%
EBITDA	0.22	0.19	-11.15	-7.15	-3.94	-2.49
EBITDA Margin	0.33%	0.29%	-24.32%	-29.61%	-25.25%	-21.15%
Depreciation & Amortization	4.37	4.02	2.63	0.77	0.41	0.22
EBIT	-4.15	-3.83	-13.78	-7.92	-4.34	-2.71
EBIT Margin	-6.10%	-5.89%	-30.06%	-32.81%	-27.88%	-23.02%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).